Hans-Peter Albert Ostler
Vorsitzender bei ECTIN RESEARCH AB
Vermögen: 279 774 $ am 30.04.2024
Aktive Positionen von Hans-Peter Albert Ostler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLIGATOR BIOSCIENCE AB | Direktor/Vorstandsmitglied | 01.06.2021 | - |
Independent Dir/Board Member | 01.06.2021 | - | |
ECTIN RESEARCH AB | Vorsitzender | 01.05.2022 | - |
HOODIN AB | Direktor/Vorstandsmitglied | 01.01.2021 | - |
Entreprenörskapital i Sverige AB
Entreprenörskapital i Sverige AB Investment Banks/BrokersFinance Entreprenörskapital i Sverige AB provides activities of securities and commodity brokers. It attracts companies to support companies in a start-up phase. It is the products of the collective wealth of risk capital experience. It desires to explore new approaches to investing in unlisted companies. It delivers benefits to investors, entrepreneurs, customers, and society. The company was founded by Raymond Peter Wendel on January 12, 2011 and is headquartered in Gothenburg, Sweden. | Direktor/Vorstandsmitglied | - | - |
Ancoria Insurance Ltd.
Ancoria Insurance Ltd. Multi-Line InsuranceFinance Ancoria Insurance Ltd. provides insurance services. It offers life insurance policies and occupational pension schemes. The company was founded by Sievert Larsson in 1987 and is headquartered in Nicosia, Cyprus. | Direktor/Vorstandsmitglied | - | - |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Vorsitzender | - | - | |
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | Direktor/Vorstandsmitglied | - | - |
O Mgmt AB | Corporate Officer/Principal | - | - |
SP HMSO Göteborg AB | Direktor/Vorstandsmitglied | - | - |
░░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Karriereverlauf von Hans-Peter Albert Ostler
Ehemalige bekannte Positionen von Hans-Peter Albert Ostler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Hans-Peter Albert Ostler
Handelshögskolan i Göteborg | Graduate Degree |
Statistik
International
Schweden | 15 |
Zypern | 2 |
Operativ
Director/Board Member | 11 |
Independent Dir/Board Member | 3 |
Chairman | 3 |
Sektoral
Health Technology | 7 |
Finance | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ALLIGATOR BIOSCIENCE AB | Health Technology |
HOODIN AB | Technology Services |
IRLAB THERAPEUTICS AB | Health Technology |
ECTIN RESEARCH AB | Health Technology |
Private Unternehmen | 10 |
---|---|
Ancoria Insurance Ltd.
Ancoria Insurance Ltd. Multi-Line InsuranceFinance Ancoria Insurance Ltd. provides insurance services. It offers life insurance policies and occupational pension schemes. The company was founded by Sievert Larsson in 1987 and is headquartered in Nicosia, Cyprus. | Finance |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Entreprenörskapital i Sverige AB
Entreprenörskapital i Sverige AB Investment Banks/BrokersFinance Entreprenörskapital i Sverige AB provides activities of securities and commodity brokers. It attracts companies to support companies in a start-up phase. It is the products of the collective wealth of risk capital experience. It desires to explore new approaches to investing in unlisted companies. It delivers benefits to investors, entrepreneurs, customers, and society. The company was founded by Raymond Peter Wendel on January 12, 2011 and is headquartered in Gothenburg, Sweden. | Finance |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Health Technology |
O Mgmt AB | |
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | Health Technology |
Improve Tec Hönö AB | |
RGNT Electric AB
RGNT Electric AB Motor VehiclesConsumer Durables RGNT Electric AB is a Swedish company that specializes in electric motorcycles. The company is based in Kungsbacka, Sweden. The company's range of motorbikes is both timeless and forward-thinking. RGNT Electric was founded in 2019 by Jonathan Åström. Göran Karlsson has been the CEO of the company since January 12, 2023. | Consumer Durables |
SP HMSO Göteborg AB | |
Lennart ekerholms stiftelse | Miscellaneous |